Satoshi Mochida
Overview
Explore the profile of Satoshi Mochida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
179
Citations
3123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takahashi S, Takeda T, Kobayashi M, Saito K, Suda K, Yamamoto N, et al.
Dig Endosc
. 2025 Mar;
PMID: 40084472
Objectives: Covered self-expandable metallic stents (CSEMS) are effective for managing malignant distal biliary obstruction (MDBO). However, migration is a significant problem, which requires prevention. The novel multihole fully CSEMS (MHSEMS),...
2.
Mizuno S, Uchida Y, Ando S, Nakao M, Sugawara K, Nakayama N, et al.
Dig Endosc
. 2025 Mar;
PMID: 40049717
Primary sclerosing cholangitis (PSC) is a progressive autoimmune hepatobiliary disease characterized by fibrotic strictures in the bile ducts, leading to chronic cholestasis and cirrhosis. Magnetic resonance cholangiopancreatography (MRCP) is a...
3.
Kawaratani H, Namisaki T, Kondo Y, Tatsumi R, Kawabe N, Tanabe N, et al.
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004887
Rifaximin is a therapeutic agent for patients with hepatic encephalopathy (HE); however, there is little data on the effects of its long-term (>1 year) administration in Japanese patients with cirrhosis....
4.
Choudhury A, Kulkarni A, Arora V, Soin A, Dokmeci A, Chowdhury A, et al.
Hepatol Int
. 2025 Feb;
19(1):1-69.
PMID: 39961976
Acute-on-chronic liver failure (ACLF) is a condition associated with high mortality in the absence of liver transplantation. There have been various definitions proposed worldwide. The first consensus report of the...
5.
Inoue I, Yoshimura N, Iidaka T, Horii C, Muraki S, Oka H, et al.
Calcif Tissue Int
. 2025 Jan;
116(1):16.
PMID: 39751686
We evaluated the role of Helicobacter pylori (H. pylori)-related chronic gastritis in the development of osteoporosis in a population-based study. A total of 1690 subjects in the cohort of the...
6.
Usui N, Imai Y, Sugawara K, Uchida Y, Nakayama N, Tomiya T, et al.
Intern Med
. 2024 Dec;
PMID: 39721685
A 64-year-old man with cirrhosis was diagnosed with unresectable hepatocellular carcinoma and treated with a combination of durvalumab and tremelimumab. The patient had no history of diabetes mellitus. Three weeks...
7.
Yamada S, Uchida Y, Kouyama J, Naiki K, Yamaguchi H, Nakayama N, et al.
Clin J Gastroenterol
. 2024 Dec;
18(1):145-153.
PMID: 39625631
A 75-year-old Japanese woman experienced persistent fatigue and progressive jaundice for 6 weeks, and was subsequently diagnosed with acute liver failure. She had not received any immunosuppressive therapies and/or antineoplastic...
8.
Tahata Y, Hikita H, Mochida S, Enomoto N, Kawada N, Ido A, et al.
Hepatol Res
. 2024 Oct;
PMID: 39470448
Aim: The incidence of and factors involved in gastroesophageal varix-related events in hepatitis C virus-related cirrhosis patients, including decompensated cirrhosis, after direct-acting antiviral therapy are unclear. Methods: We conducted a...
9.
Soma N, Uchida Y, Kouyama J, Naiki K, Usui N, Sato A, et al.
J Gastroenterol
. 2024 Oct;
60(1):96-106.
PMID: 39412575
Background: Covert hepatic encephalopathy (CHE) significantly impacts the quality of life and prognosis in patients with liver cirrhosis. This study aims to analyze the prevalence and risk factors of CHE...
10.
Shimata K, Yoon Y, Hibi T, Morinaga J, Narayanan A, Toshima T, et al.
Am J Transplant
. 2024 Aug;
24(11):2139-2140.
PMID: 39153885
No abstract available.